Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL
Clinical trial NCT04524455 · COMPLETED
Trial details
- NCT number
- NCT04524455
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-02
- Primary completion
- 2023-01-24
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.